Xencor Inc to Discuss Global Collaboration and License Agreement With Janssen Call Transcript

Oct 04, 2021 / 12:00PM GMT
Operator

Good day, and thank you for standing by. Welcome to the Xencor Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Charles Liles, Head of Communication and Investor Relations. Please go ahead.

Charles Liles - Xencor, Inc. - Associate Director and Head of Corporate Communications & IR

Thank you, and good morning, everyone. Welcome to our call to review our newest collaboration with Janssen, which we announced earlier this morning in a press release. It's available at www.xencor.com.

On the call today are Bassil Dahiyat, President and CEO; John Desjarlais, Senior Vice President and Chief Scientific Officer; Allen Yang, Senior Vice President and Chief Medical Officer; and Jeremy Grunstein, Vice President of Business Development. After some prepared remarks, we'll open the call to your questions.

Before we begin, we would like to remind you that during the course of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot